Morgan Stanley’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $247K | Sell |
|
|||||
|
2023
Q4 | $276K | Sell |
|
|||||
|
2023
Q3 | $511K | Sell |
|
|||||
|
2023
Q2 | $2.33M | Buy |
|
|||||
|
2023
Q1 | $3.49M | Buy |
|
|||||
|
2022
Q4 | $3.32M | Buy |
|
|||||
|
2022
Q3 | $7.16M | Sell |
|
|||||
|
2022
Q2 | $7.58M | Buy |
|
|||||
|
2022
Q1 | $8.86M | Buy |
|
|||||
|
2021
Q4 | $5.21M | Buy |
|
|||||
|
2021
Q3 | $3M | Sell |
|
|||||
|
2021
Q2 | $3.29M | Sell |
|
|||||
|
2021
Q1 | $7.05M | Buy |
|
|||||
|
2020
Q4 | $6.37M | Buy |
|
|||||
|
2020
Q3 | $2.44M | Sell |
|
|||||
|
2020
Q2 | $3.66M | Buy |
|
|||||
|
2020
Q1 | $35K | Sell |
|
|||||
|
2019
Q4 | $846K | Buy |
|
|||||
|
2019
Q3 | $301K | Buy |
|
|||||
|
2019
Q2 | $0 | Buy |
|